Gilead Sciences to Present at the UBS Global Life Sciences Conference on Monday, September 21
September 16 2009 - 4:30PM
Business Wire
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its
corporate presentation will be webcast from the UBS Global Life
Sciences Conference in New York.
Kevin Young, Gilead’s Executive Vice President, Commercial
Operations, along with Robin Washington, Senior Vice President and
Chief Financial Officer, will provide an overview of the company at
the UBS conference on Monday, September 21 at 9:30 a.m. Eastern
Daylight Time.
To access the live webcast or a replay via the internet log on
to www.gilead.com. Please connect to the company’s website at least
15 minutes prior to the start of the presentation to ensure
adequate time for any software download that may be necessary to
listen to the webcast. The replay will be available for 14 days
following the presentation.
About Gilead
Gilead Sciences is a biopharmaceutical company that discovers,
develops and commercializes innovative therapeutics in areas of
unmet medical need. The company’s mission is to advance the care of
patients suffering from life-threatening diseases worldwide.
Headquartered in Foster City, California, Gilead has operations in
North America, Europe and Australia.
For more information on Gilead
Sciences, please visit www.gilead.com orcall the Gilead Public
Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Sep 2024 to Oct 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Oct 2023 to Oct 2024